How pharmacogenomics will play a role in the management of asthma

Am J Respir Crit Care Med. 2005 Jul 1;172(1):12-8. doi: 10.1164/rccm.200412-1635OE. Epub 2005 Mar 18.

Authors

Michael E Wechsler¹, Elliot Israel

Affiliation

¹ Pulmonary and Critical Care Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

PMID: 15778484
DOI: 10.1164/rccm.200412-1635OE

No abstract available

Publication types

Review

MeSH terms

Adrenal Cortex Hormones / pharmacology
Adrenal Cortex Hormones / therapeutic use
Adrenergic beta-Agonists / pharmacology
Adrenergic beta-Agonists / therapeutic use
Anti-Asthmatic Agents / pharmacology*
Anti-Asthmatic Agents / therapeutic use*
Asthma / drug therapy*
Asthma / genetics*
Drug Therapy, Combination
Humans
Leukotriene Antagonists / pharmacology
Leukotriene Antagonists / therapeutic use
Pharmacogenetics* / methods
Polymorphism, Single Nucleotide / genetics
Treatment Outcome

Substances

Adrenal Cortex Hormones
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Leukotriene Antagonists